Has Robert Graham, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,267,640 in general payments to Robert Graham, MD across 210 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Graham, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Graham, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Graham, MD

Orthopaedic Surgery · Austin, TXNPI 1215935820

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $6,149,736 of the $6,267,640 with a category attached, or 98.1%. Stryker accounts for 100.0% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $1,637,236, 4.2 times the $386,522 reported in 2019. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,267,640in general payments, 2019–2025

Across 210 payments — averaging $29,846 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$6.3M
Axogen$207
Pacira Therapeutics, Inc.$109
Catalyst Orthoscience$108
Arthrex$50
Abbott$25
plus $36 from 2 others

$24,818in research payments, 2019–2025

Across 17 payments — averaging $1459.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$25K

What the payments were for

Royalty or licence$6,149,73698%
Consulting fees$70,1251%
Speaking & faculty fees$38,1251%
Travel & lodging$7,4610%
Food & beverage$2,1940%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker(2 entities)	199	$6,267,105
Axogen	2	$207
Pacira Therapeutics, Inc.	1	$109
Catalyst Orthoscience	1	$108
Arthrex	2	$50
Abbott	2	$25
Amgen	2	$23
Forte Bio-pharma LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AEQUALIS PERFORM$5,184,451
AEQUALIS$761,321
TORNIER PERFORM REVERSED GLENOID$253,464
R&D UPPER EXT$38,382
TORNIER PERFORM REVERSED AUGMENTED GLENOID$12,750
TORNIER PERFORM ANATOMIC AUGMENTED GLENOID$12,625
BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$10,122
BLUEPRINT PSI SYSTEM$8,500
MAKO$4,000
R&D EXTREMITIES$3,125
AEQUALIS ASCEND FLEX$2,500
ICONIX$1,577
AEQUALIS PERFORM REVERSED$168
NANOPASS$165
SALVATION$157
VARIAX$145
1688$135
ACCOLADE$135
CROSSFIRE$135
FORMULA$135

How this compares

$6,267,640 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$229,149

Medicare patients

377

Services billed

5,038

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	157	$2,643
Meloxicam	270	$617
Celecoxib	29	$415
Promethazine Hcl	82	$363
Cyclobenzaprine Hcl	38	$154
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	16	$150
Tramadol Hcl	25	$80
Acetaminophen-CodeineAcetaminophen With Codeine	11	$58
Methylprednisolone	14	$57
Amoxicillin	26	$30
Alprazolam	11	$3

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Austin

Eric HeinrichAustin$907K
David DodginAustin$704K
Stephen BurkhartSan Antonio$185.3M
Kirby HittTemple$9.1M
Richard JonesDallas$6.3M
Stefan KreuzerHouston$6.2M
Michael WirthSan Antonio$4.5M
Stephen IncavoHouston$4.3M
Thomas EdwardsHouston$4.1M
James BrodskyDallas$2.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →